<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Med Biol Eng Comput</journal-id>
      <journal-id journal-id-type="iso-abbrev">Med Biol Eng Comput</journal-id>
      <journal-title-group>
        <journal-title>Medical &amp; Biological Engineering &amp; Computing</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0140-0118</issn>
      <issn pub-type="epub">1741-0444</issn>
      <publisher>
        <publisher-name>Springer Berlin Heidelberg</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18320249</article-id>
      <article-id pub-id-type="pmc">2329737</article-id>
      <article-id pub-id-type="publisher-id">315</article-id>
      <article-id pub-id-type="doi">10.1007/s11517-008-0315-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Special Issue</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Duncker</surname>
            <given-names>Dirk J.</given-names>
          </name>
          <address>
            <email>d.duncker@erasmusmc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Beer</surname>
            <given-names>Vincent J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Merkus</surname>
            <given-names>Daphne</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">000000040459992X</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution>Experimental Cardiology, Thoraxcenter, Cardiovascular Research Institute COEUR, Erasmus MC, </institution><institution>University Medical Center Rotterdam, </institution></institution-wrap>Dr Molewaterplein 50, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>5</day>
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2008</year>
      </pub-date>
      <volume>46</volume>
      <issue>5</issue>
      <fpage>485</fpage>
      <lpage>497</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>10</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>1</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2008</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>The mechanism underlying the progressive deterioration of left ventricular (LV) dysfunction after myocardial infarction (MI) towards overt heart failure remains incompletely understood, but may involve impairments in coronary blood flow regulation within remodelled myocardium leading to intermittent myocardial ischemia. Blood flow to the remodelled myocardium is hampered as the coronary vasculature does not grow commensurate with the increase in LV mass and because extravascular compression of the coronary vasculature is increased. In addition to these factors, an increase in coronary vasomotor tone, secondary to neurohumoral activation and endothelial dysfunction, could also contribute to the impaired myocardial oxygen supply. Consequently, we explored, in a series of studies, the alterations in regulation of coronary resistance vessel tone in remodelled myocardium of swine with a 2 to 3-week-old MI. These studies indicate that myocardial oxygen balance is perturbed in remodelled myocardium, thereby forcing the myocardium to increase its oxygen extraction. These perturbations do not appear to be the result of blunted &#x3B2;-adrenergic or endothelial NO-mediated coronary vasodilator influences, and are opposed by an increased vasodilator influence through opening of K<sub>ATP</sub> channels. Unexpectedly, we observed that despite increased circulating levels of noradrenaline, angiotensin II and endothelin-1, &#x3B1;-adrenergic tone remained negligible, while the coronary vasoconstrictor influences of endogenous endothelin and angiotensin II were virtually abolished. We conclude that, early after MI, perturbations in myocardial oxygen balance are observed in remodelled myocardium. However, adaptive alterations in coronary resistance vessel control, consisting of increased vasodilator influences in conjunction with blunted vasoconstrictor influences, act to minimize the impairments of myocardial oxygen balance.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Myocardial infarction</kwd>
        <kwd>Swine</kwd>
        <kwd>Coronary blood flow</kwd>
        <kwd>Myocardial oxygen balance</kwd>
        <kwd>Exercise</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; International Federation for Medical and Biological Engineering 2008</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Heart failure constitutes a major cardiovascular disorder of which the incidence and prevalence are increasing, principally due to an increased survival of acute myocardial infarction (MI) in conjunction with an ageing population. The mechanism underlying the progressive deterioration of left ventricular (LV) dysfunction towards overt heart failure remains incompletely understood, but may involve (1) loss of cardiomyocytes through apoptosis [<xref ref-type="bibr" rid="CR75">75</xref>], (2) a primary reduction in contractile function of the surviving myocardium [<xref ref-type="bibr" rid="CR97">97</xref>], and/or (3) alterations in extracellular matrix leading to progressive LV dilation [<xref ref-type="bibr" rid="CR87">87</xref>]. In addition, myocardial blood flow (MBF) abnormalities, resulting in impaired myocardial O<sub>2</sub> delivery to the non-infarcted regions (leading to secondary contractile dysfunction and/or enhanced apoptosis), have been suggested to contribute to the progression of LV dysfunction after MI [<xref ref-type="bibr" rid="CR99">99</xref>]. For example, in vivo studies in rats [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] and swine [<xref ref-type="bibr" rid="CR108">108</xref>] indicate a reduction in MBF reserve of up to 35% in the surviving remodelled LV myocardium, 3&#x2013;8 weeks after infarction. Furthermore, in patients with overt heart failure [<xref ref-type="bibr" rid="CR94">94</xref>], but also in patients with only asymptomatic LV dysfunction [<xref ref-type="bibr" rid="CR95">95</xref>], flow reserve is reduced in the non-stenotic myocardial regions. In line with these clinical observations, we observed in a porcine model of post-infarct remodelling that during increased O<sub>2</sub>-demand induced by exercise, the increase in coronary blood flow (CBF) is impaired resulting in perturbations in oxygen delivery [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. The reduction in flow reserve and the perturbed oxygen delivery during exercise are caused, at least in part, by insufficient growth of the coronary vasculature to maintain flow capacity commensurate with myocardial hypertrophy, in conjunction with a decrease in diastolic pressure time index resulting from the elevated heart rate and particularly elevated LV diastolic pressures [<xref ref-type="bibr" rid="CR43">43</xref>]. In addition, coronary vasomotor tone may also be increased secondary to neurohumoral activation and endothelial dysfunction, further adding to the perturbations in CBF. However, little is known about the alterations in vasomotor control in coronary resistance vessels within remodelled myocardium (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). For this reason we undertook a series of studies to determine whether neurohumoral (autonomic nervous system and renin-angiotensin system), local metabolic, and endothelial control mechanisms of coronary resistance vessel tone are altered in swine with remodelled myocardium produced by a recent MI.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Alterations in determinants of oxygen supply and demand in remodelled myocardium in swine with a 3-week-old myocardial infarction (<italic>MI</italic>). The net effect of these alterations is a decrease in oxygen supply/demand ratio</p></caption><graphic xlink:href="11517_2008_315_Fig1_HTML" id="MO1"/></fig>
</p>
    </sec>
    <sec id="Sec2">
      <title>Characteristics of LV remodelling and dysfunction after MI in swine</title>
      <p>Left ventricular remodelling was produced by permanent ligation of the left circumflex coronary artery. This ligation results in a circumscribed transmural infarction of the lateral LV wall, comprising 20&#x2013;25% of the total LV [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. LV dysfunction in awake resting MI swine is characterised by 20&#x2013;30% decreases in cardiac output, stroke volume and LVdP/d<italic>t</italic>
<sub>max</sub> and a tripling of LV filling pressure. This difference between LVdP/d<italic>t</italic>
<sub>max</sub>, cardiac output and stroke volume in normal and MI swine remained constant between &#x223C;10 and &#x223C;32&#xA0;days, indicating that the degree of LV dysfunction and the circulatory adaptations in MI were stable during this observation period [<xref ref-type="bibr" rid="CR43">43</xref>]. Similarly, we observed that already during the first week after infarction significant LV remodelling occurs, consisting of LV dilation and hypertrophy that remain fairly stable between 1 and 6&#xA0;weeks after infarction [<xref ref-type="bibr" rid="CR98">98</xref>]. During exercise, cardiac output, LV systolic pressure and LVdP/d<italic>t</italic>
<sub>max</sub> increased almost in parallel in MI and normal animals up to 3&#xA0;km/h, after which curves diverged (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>); 4&#xA0;km/h was also the maximally attainable exercise level for most MI swine.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Cardiovascular responses to exercise in normal swine and swine with a &#x223C;3-week-old MI. 0<sub>L</sub>&#xA0;=&#xA0;lying, 0<sub>S</sub>&#xA0;=&#xA0;standing. Data are mean&#xA0;&#xB1;&#xA0;SEM; *<italic>P</italic>&#xA0;&lt;&#xA0;0.05 versus 0<sub>L</sub>, &#x2020;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 MI versus normal a corresponding exercise level. Data are from Haitsma et al. [<xref ref-type="bibr" rid="CR43">43</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig2_HTML" id="MO2"/></fig>
</p>
      <p>Left ventricular dysfunction produced by MI results in neurohumoral activation, characterized by a trend towards elevated plasma levels of catecholamines, but normal circulating levels of renin, angiotensin II and aldosterone at rest. The latter may have been due to the increments in atrial natriuretic peptide (ANP) and endothelin, which can suppress renin and aldosterone release [<xref ref-type="bibr" rid="CR83">83</xref>]. In resting MI swine, ANP doubled within 24&#xA0;h, recovered to 50% above normal values within 2&#xA0;weeks and remained stable between 2 and 6&#xA0;weeks after infarction, while renin and norepinephrine levels remained normal under resting conditions [<xref ref-type="bibr" rid="CR98">98</xref>]. In contrast to the discrete neurohumoral activation in resting swine with MI, exercise resulted in exaggerated increases in catecholamines and ANP and increases in endothelin, angiotensin II, and aldosterone (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). While resting circulating levels of norepinephrine were still normal and the relative sympathetic drive in response to exercise was preserved in MI, the cardiac responsiveness to exercise (both heart rate and LVdP/d<italic>t</italic>
<sub>max</sub>) was already blunted 3&#xA0;weeks after infarction [<xref ref-type="bibr" rid="CR43">43</xref>], likely due to &#x3B2;-adrenoceptor desensitization and/or downregulation [<xref ref-type="bibr" rid="CR100">100</xref>].
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Neurohumoral responses in exercising swine with a &#x223C;3-week-old MI. In the norepinephrine, epinephrine and dopamine panels, data shown for N represent 0<sub>L</sub>, 1, 2, 3, 4 and 5&#xA0;km/h and data for MI represent 0<sub>L</sub>, 1, 2, 3 and 4&#xA0;km/h. In all other panels, data shown for N represent 0<sub>L</sub>, 1, 3 and 5&#xA0;km/h and data for MI represent 0<sub>L</sub>, 1, 3 and 4&#xA0;km/h. Mean data points were fitted with second order curves. VO<sub>2</sub>&#xA0;=&#xA0;O<sub>2</sub>-consumption. Data are mean&#xA0;&#xB1;&#xA0;SEM; *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 vs 0<sub>L</sub>, <sup>&#x2020;</sup>
<italic>P&#xA0;&lt;&#xA0;</italic>0.05 MI versus Normal. Data are from Haitsma et al [<xref ref-type="bibr" rid="CR43">43</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig3_HTML" id="MO3"/></fig>
</p>
    </sec>
    <sec id="Sec3">
      <title>Myocardial O<sub>2</sub> balance in remodelled myocardium</title>
      <p>Marked decreases in myocardial perfusion occur in pacing-induced severe heart failure in swine [<xref ref-type="bibr" rid="CR88">88</xref>] and dogs [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR90">90</xref>], especially in the more vulnerable subendocardial layers. Although one study in dogs indicated that the lower MBF is principally the result of a lower myocardial O<sub>2</sub> consumption (MVO<sub>2</sub>) [<xref ref-type="bibr" rid="CR90">90</xref>], studies in swine suggest that the impaired perfusion is, at least in part, responsible for the deterioration of LV function because the interstitial edema and disruption of collagen fibers in the subendocardium resemble the ultrastuctural changes that occur with recurrent ischemia [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. In animal models of severe pressure-overload induced LV hypertrophy, selective underperfusion of the subendocardium can produce myocardial ischemia during exercise and result in post-exercise myocardial stunning [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. The contribution of perfusion abnormalities in the remote surviving myocardium to LV dysfunction after a MI remains unclear. Studies in rats demonstrated a 25&#x2013;40% reduction in coronary flow reserve in the surviving myocardium at four [<xref ref-type="bibr" rid="CR55">55</xref>] and eight [<xref ref-type="bibr" rid="CR54">54</xref>] weeks after MI. Similarly, maximum subendocardial blood flow was blunted by 40% in anesthetized swine with heart failure 3&#xA0;weeks after a MI [<xref ref-type="bibr" rid="CR108">108</xref>]. We hypothesized that the decreased flow reserve could limit the increase in MBF to the hypertrophied myocardium during exercise when hemodynamic abnormalities and neurohumoral activation are exacerbated, thereby impairing myocardial O<sub>2</sub>-supply.</p>
      <p>Three weeks after infarction, blood flow per gram of myocardium in the (remote) LV anterior wall of resting swine with MI was similar to that in normal animals (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>), confirming previous studies in rats and swine [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Interestingly, we observed a trend towards slightly higher blood flows in the outer two layers (<italic>P</italic>&#xA0;<italic>=&#xA0;</italic>0.09), suggesting that despite hypertrophy of the surviving myocardium, metabolic demand in the outer, but not the inner, layers was still slightly elevated, 3&#xA0;weeks after infarction [<xref ref-type="bibr" rid="CR43">43</xref>]. During exercise, MBF increased but was redistributed in favor of the subepicardium in MI compared to normal swine. These perturbations were most likely due to increased extravascular compressive forces, resulting from a reduction in diastolic time fraction (secondary to impaired relaxation and increased heart rate) and elevated LV filling pressures [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR97">97</xref>], that impede MBF, particularly in the subendocardial layers. The decreased MBF necessitated a small increase in O<sub>2</sub> extraction that resulted in a slightly lower coronary venous O<sub>2</sub> tension (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>), which actually may have been underestimated as the lower myocardial capillary density in swine with MI possibly prevented a greater increase in O<sub>2 </sub>extraction [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. The observation that O<sub>2</sub> extraction was forced to increase indicates that increases in extravascular forces are not fully compensated by a concomitant lowering of coronary vasomotor tone in remodelled myocardium during exercise. These observations prompted us to further investigate the control of coronary vasomotor tone in remodelled myocardium during exercise.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Myocardial blood flow and O<sub>2</sub>-balance in the left ventricular anterior wall of N and MI &#x223C;3&#xA0;weeks after myocardial infarction. <italic>Epi</italic> subepicardial, <italic>OM</italic> outer mid; <italic>IM</italic> inner mid; <italic>Endo</italic> subendocardial. MVO<sub>2</sub>&#xA0;=&#xA0;myocardial O<sub>2</sub>-consumption; MEO<sub>2</sub>&#xA0;=&#xA0;myocardial O<sub>2</sub> extraction; CVPO<sub>2</sub>&#xA0;=&#xA0;coronary venous O<sub>2</sub> tension In the top left panel data myocardial blood flow data are shown for resting (Rest, lying) conditions, and during maximum exercise (Ex, 5&#xA0;km/h in N and 4&#xA0;km/h in MI). Data are mean&#xA0;&#xB1;&#xA0;SEM; *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 versus 0<sub>L</sub>, <sup>&#x2020;</sup>
<italic>P&#xA0;&lt;&#xA0;</italic>0.05 MI versus Normal. Data are from Haitsma et al [<xref ref-type="bibr" rid="CR43">43</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig4_HTML" id="MO4"/></fig>
</p>
    </sec>
    <sec id="Sec4">
      <title>Vasomotor control of the coronary microcirculation in remodelled myocardium</title>
      <sec id="Sec5">
        <title>Neurohumoral control</title>
        <p>Cardiac dysfunction is accompanied by a hemodynamic defense reaction consisting of salt and water retention, peripheral vasoconstriction and cardiac stimulation, which serves to partially restore cardiac output and to increase systemic vascular resistance in order to maintain arterial pressure [<xref ref-type="bibr" rid="CR56">56</xref>]. An integral part of this defense reaction involves alterations in autonomic balance, consisting of an increase in sympathetic activity and a decrease in parasympathetic activity [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
        <sec id="Sec6">
          <title>Sympathetic control</title>
          <p>In patients with advanced heart failure plasma noradrenaline levels are already increased under resting conditions [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. These increased levels result principally from increased sympathetic nerve activity although impaired reuptake may also contribute [<xref ref-type="bibr" rid="CR56">56</xref>]. Prolonged exposure to elevated noradrenaline levels results in desensitization and downregulation of the &#x3B2;-adrenergic receptors [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. During exercise, the increases in catecholamine levels are exaggerated in patients with heart failure as compared to healthy controls [<xref ref-type="bibr" rid="CR35">35</xref>], which is aimed at maintaining chronotropic and inotropic responses to exercise [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
          <p>Also in swine with LV dysfunction produced by a 2&#x2013;3-week-old MI, we observed exaggerated increases in arterial and coronary venous catecholamine levels during treadmill exercise [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], at a time when resting catecholamine levels were still in the normal range [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. The exaggerated exercise-induced increases in catecholamine levels reflect increased sympathetic activity, which acts to maintain the chronotropic and inotropic responses to acute exercise. This concept is supported by the observation that &#x3B2;-adrenoceptor blockade produced slightly greater decreases in the chronotropic response during exercise in MI as compared to normal swine. In contrast, &#x3B2;-adrenoceptor blockade in MI swine resulted in a smaller decrease in global LV contractility compared to normal swine, in particular during exercise. The latter findings are consistent with a reduced left ventricular myocardial &#x3B2;-adrenoceptor responsiveness [<xref ref-type="bibr" rid="CR100">100</xref>].</p>
          <p>In normal swine and dogs, &#x3B2;-adrenergic receptor activation contributes to coronary vasodilatation during exercise [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. The &#x3B2;-adrenergic coronary vasodilatation results in an increase in myocardial oxygen delivery that is commensurate with the increase in oxygen consumption, so that myocardial oxygen extraction and hence coronary venous O<sub>2</sub> tension remain constant (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). In MI swine, the net &#x3B2;-adrenergic vasodilator influence on the coronary circulation is maintained. However, in view of the exaggerated increases in catecholamine levels during exercise, these findings suggest a diminished &#x3B2;-adrenergic responsiveness of the coronary resistance vessels after MI.
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Effect of saline, &#x3B1;-adrenoceptor blockade (phentolamine, 1&#xA0;mg/kg iv) and/or &#x3B2;-adrenoceptor blockade (propranolol, 0.5&#xA0;mg/kg iv) and of muscarinic receptor blockade (atropine, 30&#xA0;&#x3BC;g/kg/min, iv) and/or &#x3B2;-adrenoceptor blockade (propranolol, 0.5&#xA0;mg/kg iv) on the response of coronary venous O<sub>2</sub> tension (CVPO<sub>2</sub>) plotted as a function of myocardial O<sub>2</sub> consumption (MVO<sub>2</sub>) in seven normal and 7 MI swine. *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 versus corresponding Control; <sup>&#x2020;</sup>
<italic>P&#xA0;</italic>&lt;&#xA0;0.05 Atropine&#xA0;+&#xA0;Propranolol versus corresponding Atropine or Phentolamine&#xA0;+&#xA0;Propranolol versus corresponding Phentolamine; Data are mean&#xA0;&#xB1;&#xA0;SEM. Data are from Duncker et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig5_HTML" id="MO5"/></fig>
</p>
          <p>In dogs, &#x3B1;-adrenoceptor activation limits the exercise-induced increase in CBF, thereby necessitating an increase in myocardial O<sub>2</sub> extraction, which leads to a decrease in coronary venous O<sub>2</sub> tension [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. In contrast, &#x3B1;-adrenoceptors do not contribute to regulation of coronary blood flow in normal swine during exercise [<xref ref-type="bibr" rid="CR27">27</xref>]. We found that, in accordance with our findings in normal swine, administration of the &#x3B1;-adrenoceptor blocker phentolamine had also no effect on coronary venous O<sub>2</sub> tension of MI swine (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). These findings indicate that even in the presence of exaggerated increments in catecholamine levels in MI swine during exercise, &#x3B1;-adrenoceptors do not contribute to regulation of tone in porcine coronary resistance vessels [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
        </sec>
        <sec id="Sec7">
          <title>Parasympathetic control</title>
          <p>The shift in the sympathovagal balance, with an increased sympathetic activity [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] and a blunted parasympathetic activity is reflected in reduced heart rate variability and reduced baroreceptor reflex sensitivity [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR76">76</xref>] in patients with advanced heart failure. We observed that a maximal dose of the muscarinic receptor blocker atropine produced a similar increase in resting heart rate in swine with MI as compared to normal swine, suggesting preserved parasympathetic activity under resting conditions [<xref ref-type="bibr" rid="CR23">23</xref>]. In contrast, the atropine-induced increase in heart rate during exercise (particularly at higher exercise levels) was blunted in MI swine, while the increase in LVdP/d<italic>t</italic>
<sub>max</sub> was abolished [<xref ref-type="bibr" rid="CR23">23</xref>]. These results are consistent with the concept that gradual inhibition of parasympathetic influence on the heart during exercise was more pronounced in swine with MI compared to normal swine. Importantly, these findings suggest that after MI, at a time when parasympathetic tone under basal resting conditions is normal, a more pronounced inhibition of parasympathetic tone occurs with increasing exercise intensity. Since parasympathetic activity can presynaptically modulate sympathetic activity [<xref ref-type="bibr" rid="CR1">1</xref>], it is likely that the greater degree of withdrawal of parasympathetic tone during exercise contributed to the exaggerated increase in sympathetic activity during exercise. This is also supported by the observation that in the presence of propranolol, the effects of atropine were no longer different between MI and normal swine [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
          <p>In resting dogs, parasympathetic activity exerts a direct vasodilator influence on coronary resistance vessels that is mediated via nitric oxide [<xref ref-type="bibr" rid="CR109">109</xref>]. In contrast, in resting swine parasympathetic activity exerts an indirect vasoconstrictor effect on the coronary resistance vessels (which wanes at increasing exercise intensity) that is mediated via inhibition of &#x3B2;-adrenergic vasodilatation [<xref ref-type="bibr" rid="CR27">27</xref>]. In contrast to the loss of the inhibitory influence of the parasympathetic system on &#x3B2;-adrenoceptor mediated cardiostimulation, we observed that its effects on the coronary circulation were maintained in MI compared to normal swine (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR23">23</xref>]. These findings indicate that at this stage of LV dysfunction, parasympathetic control of &#x3B2;-adrenoceptor-mediated coronary vasodilatation is unimpaired.</p>
        </sec>
        <sec id="Sec8">
          <title>Angiotensin II</title>
          <p>The renin-angiotensin system plays an important role in cardiovascular homeostasis by contributing to the regulation of blood volume, blood pressure and vascular tone. Angiotensin II (ANG-II) exerts its effects on vascular tone through binding to the AT<sub>1</sub>-receptor, resulting in vasoconstriction, as well as binding to the AT<sub>2</sub>-receptor, evoking vasodilation [<xref ref-type="bibr" rid="CR14">14</xref>]. Both receptor subtypes have been identified in the coronary microcirculation [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR107">107</xref>], suggesting that endogenous ANG-II may contribute to the regulation of coronary vascular tone and to the regulation of myocardial perfusion. Under pathological circumstances, i.e. after MI, the renin-angiotensin system is activated, resulting in increased plasma levels of ANG-II, particularly during exercise [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Moreover, there is evidence that AT<sub>1</sub>-receptor density in the viable region of the myocardium is increased early after MI [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR98">98</xref>], suggesting that its vasoconstrictor influence on the coronary vasculature could be increased, which may limit myocardial perfusion thereby exacerbating LV dysfunction.</p>
          <p>Contrary to our hypothesis, we observed a loss of ANG-II induced vasoconstrictor influence, reflected by the lack of increase in coronary venous O<sub>2</sub> tension (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>), despite increased plasma ANG-II levels and maintained AT<sub>1</sub> receptor densities in coronary arterioles isolated from remodelled myocardium of MI swine [<xref ref-type="bibr" rid="CR68">68</xref>]. It is unlikely that a generalized loss of vasodilator capacity in the remote myocardium contributed to the blunted vasodilator response to the AT<sub>1</sub> receptor blocker irbesartan, as we have previously shown that vasodilation produced by nitroprusside is unperturbed [<xref ref-type="bibr" rid="CR44">44</xref>]. Although an increased AT<sub>2</sub>-receptor expression could have acted to limit ANG-II induced vasoconstriction [<xref ref-type="bibr" rid="CR84">84</xref>] this is unlikely as AT<sub>2</sub>-mRNA was not altered in coronary arteries from patients with ischemic heart disease [<xref ref-type="bibr" rid="CR103">103</xref>]. Moreover, the dramatic increases in ANG-II levels that we observed after irbesartan did not result in enhanced, but rather blunted, coronary vasodilation [<xref ref-type="bibr" rid="CR68">68</xref>]. Therefore, the observation of a reduced vasoconstrictor influence of endogenous ANG-II is best explained by AT<sub>1</sub>-receptor-desensitization, which is in accordance with studies in dogs with pacing-induced heart failure [<xref ref-type="bibr" rid="CR78">78</xref>], in rats with pressure-overload LV hypertrophy [<xref ref-type="bibr" rid="CR63">63</xref>], and in rats with LV remodeling after MI [<xref ref-type="bibr" rid="CR84">84</xref>], that demonstrated blunted vasoconstrictor responses to exogenous ANG-II.
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p>Effect of AT<sub>1</sub>-receptor blockade with irbesartan (1&#xA0;mg/kg iv) on the relation between myocardial O<sub>2</sub> consumption (MVO<sub>2</sub>) and coronary venous O<sub>2</sub> tension (CVPO<sub>2</sub>) in normal swine and swine with a 2&#x2013;3-week-old myocardial infarction. Data are means&#xA0;&#xB1;&#xA0;SE; *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 versus corresponding control relation, <sup>&#x2020;</sup>
<italic>P&#xA0;</italic>&lt;&#xA0;0.05 effect of irbesartan different in MI versus Normal animals. Data are from Merkus et al. [<xref ref-type="bibr" rid="CR68">68</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig6_HTML" id="MO6"/></fig>
</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Local metabolic control</title>
        <sec id="Sec10">
          <title>Adenosine</title>
          <p>Adenosine has been proposed to be a metabolic messenger that regulates coronary resistance vessel tone in response to changes in metabolic needs of the myocardium [<xref ref-type="bibr" rid="CR5">5</xref>]. However, adenosine receptor blockade with 8PT and/or augmenting adenosine catabolism with intracoronary adenosine deaminase had either no effect [<xref ref-type="bibr" rid="CR3">3</xref>] or produced a small decrease [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR93">93</xref>] in basal coronary venous O<sub>2</sub> tension (reflecting vasoconstriction), but did not interfere with the normal exercise-induced increase in CBF and O<sub>2</sub> delivery [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR93">93</xref>], indicating that adenosine is not critical for the exercise-induced coronary vasodilation or that loss of adenosine-mediated vasodilation can be compensated for by increased contribution of other vasodilator pathways to maintain adequate metabolic vasodilation.</p>
          <p>In contrast to the lack of evidence for an essential role of adenosine in regulation of CBF under physiological conditions, endogenously released adenosine does contribute to coronary vasodilation when there is insufficient supply of O<sub>2</sub> [<xref ref-type="bibr" rid="CR61">61</xref>]. Similarly, adenosine production could be increased in the remodelled myocardium after MI as a result of the perturbations in the myocardial O<sub>2</sub> balance [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. However, we found no evidence for an increased contribution of adenosine to regulation of coronary resistance vessel tone in remodelled myocardium of swine with a recent MI [<xref ref-type="bibr" rid="CR71">71</xref>], as adenosine receptor blockade with 8PT caused a similar decrease in coronary venous O<sub>2</sub> tension in post-infarct remodelled hearts and normal hearts both at rest and during exercise (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>). These findings are in agreement with observations in dogs with pressure-overload LV hypertrophy, in which adenosine receptor blockade did not affect CBF either at rest or during exercise [<xref ref-type="bibr" rid="CR65">65</xref>].
<fig id="Fig7"><label>Fig.&#xA0;7</label><caption><p>Effect of the adenosine receptor antagonist 8-phenyltheophylline (<italic>8PT</italic>, 5&#xA0;mg/kg iv), the K<sub>ATP</sub> channel blocker glibenclamide (Glib, 3&#xA0;mg/kg iv) or their combination on myocardial O<sub>2 </sub>balance in the LV anterior free wall of normal swine and swine with a recent MI. MVO<sub>2</sub>&#xA0;=&#xA0;myocardial O<sub>2</sub> consumption; CVPO<sub>2</sub>&#xA0;=&#xA0;coronary venous O<sub>2</sub> tension; Data are mean&#xA0;&#xB1;&#xA0;SEM; Data are mean&#xA0;&#xB1;&#xA0;SEM; *<italic>P</italic>&#xA0;&#x2264;&#xA0;0.05 versus corresponding control; <sup>&#x2020;</sup>
<italic>P</italic>&#xA0;&#x2264;&#xA0;0.05 effect of Glib was blunted at higher MVO<sub>2</sub> levels (Glib&#xA0;&#xD7;&#xA0;MVO<sub>2</sub>); <sup>&#x2021;</sup>
<italic>P</italic>&#xA0;&#x2264;&#xA0;0.05 effect of Glib different after MI (Glib&#xA0;&#xD7;&#xA0;MVO<sub>2</sub>&#xA0;&#xD7;&#xA0;MI). Data are from Merkus et al. [<xref ref-type="bibr" rid="CR71">71</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig7_HTML" id="MO7"/></fig>
</p>
          <p>Several reasons could be forwarded for the failure to observe a larger contribution of adenosine to regulation of coronary resistance vessel tone. First, it is possible that the perturbations in the myocardial O<sub>2</sub> balance were too mild to increase adenosine production. Second, the activity of enzymes that regulate tissue adenosine levels may have been altered [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. For example, the activity of adenosine deaminase, the enzyme responsible for breakdown of adenosine to inosine, was found to be elevated in LV hypertrophy [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Furthermore, there is evidence that the activity of cytosolic 5&#x2032; nucleotidase, which converts 5&#x2032;AMP to adenosine, is lower in certain models of pressure-overload [<xref ref-type="bibr" rid="CR13">13</xref>] and volume-overload [<xref ref-type="bibr" rid="CR10">10</xref>] induced LV hypertrophy, which could be related to intermittent hypoperfusion of the hypertrophic myocardium [<xref ref-type="bibr" rid="CR41">41</xref>]. Together these enzymatic alterations, which act to decrease myocardial levels of adenosine may have prevented a significant increase in myocardial adenosine levels in the post MI remodelled hearts.</p>
          <p>Finally, it is possible that an increased role of adenosine in hypertrophied myocardium is masked by an increased contribution of other vasodilator systems during adenosine receptor blockade, as the process of metabolic vasodilation is thought to be mediated through multiple parallel or redundant pathways. Thus, K<sub>ATP</sub> channel activity may have increased in response to adenosine receptor blockade to compensate for the loss of adenosine-mediated vasodilation. Hence, we evaluated the interactions between these vasodilator pathways.</p>
        </sec>
        <sec id="Sec11">
          <title>K<sub>ATP</sub> channels</title>
          <p>In addition to the role of K<sub>ATP</sub> channels in the regulation of CBF under physiological conditions [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], there is evidence for an increased K<sub>ATP</sub> channel activity in the coronary circulation of remodelled hearts. For example, in anesthetized dogs with pacing-induced severe heart failure [<xref ref-type="bibr" rid="CR106">106</xref>], the K<sub>ATP</sub> channel blocker glibenclamide resulted in an exaggerated vasoconstrictor response as compared to normal dogs. Interestingly, in dogs subjected to only 1&#xA0;week of pacing (when LV function was still normal), K<sub>ATP</sub> channel activity was not different from normal dogs [<xref ref-type="bibr" rid="CR106">106</xref>], suggesting that K<sub>ATP</sub> channel activity in the basal resting state was only enhanced in the presence of overt heart failure. Similarly, in awake dogs with compensated pressure-overload induced LV hypertrophy, the reduction in CBF produced by glibenclamide was similar to that in normal dogs [<xref ref-type="bibr" rid="CR65">65</xref>]. During exercise, however, glibenclamide produced a greater reduction in CBF in hypertrophied hearts, indicating increased K<sub>ATP</sub>-channel contribution to coronary vasodilation when O<sub>2</sub> requirements of the hypertrophied heart were augmented [<xref ref-type="bibr" rid="CR65">65</xref>].</p>
          <p>In swine with MI-induced moderate LV remodeling and dysfunction, glibenclamide caused a marked decrease in coronary venous O<sub>2</sub> tension in remodelled left ventricle under resting conditions, that was similar to the decrease in coronary venous O<sub>2</sub> tension in normal hearts (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>; [<xref ref-type="bibr" rid="CR71">71</xref>]). Although the vasoconstriction under resting conditions in response to K<sub>ATP</sub> channel blockade was similar in normal and post-MI remodelled hearts, the responses to exercise were different. Thus in normal swine, the effects of K<sub>ATP</sub> channel blockade waned during exercise, suggesting that other vasodilator systems compensated for the loss of K<sub>ATP</sub> channels during exercise. In contrast, in the post-MI remodelled hearts the effects of K<sub>ATP</sub> channel blockade were maintained during exercise. Our findings, which are consistent with the observations in dogs [<xref ref-type="bibr" rid="CR65">65</xref>], support the hypothesis that K<sub>ATP</sub> channel opening is of greater importance in resistance vessel dilation during exercise in hypertrophied than in normal hearts. It is likely that with the progression from LV dysfunction to overt heart failure, increased K<sub>ATP</sub> channel activity may also become important under resting conditions [<xref ref-type="bibr" rid="CR106">106</xref>].</p>
        </sec>
        <sec id="Sec12">
          <title>Interaction between K<sub>ATP</sub> channels and adenosine</title>
          <p>In contrast to the canine heart in which adenosine can act as a back-up system [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR81">81</xref>], adenosine and K<sub>ATP</sub> channels appear to exert additive vasodilator influences on coronary vasomotor tone in the normal porcine heart [<xref ref-type="bibr" rid="CR67">67</xref>]. Thus, the coronary vasoconstriction that occurs in response to combined adenosine receptor blockade and K<sub>ATP</sub> channel blockade equalled the sum of the vasoconstriction induced by blockade of the individual pathways. Adenosine mediates its vasodilator effect on porcine coronary resistance vessels via K<sub>ATP</sub>, K<sub>Ca</sub> and K<sub>v</sub> channels [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR46">46</xref>&#x2013;<xref ref-type="bibr" rid="CR48">48</xref>] It is therefore possible that following K<sub>ATP</sub> channel blockade adenosine maintained its vasodilator influence via K<sub>Ca</sub> and/or K<sub>v</sub> channels.</p>
          <p>In contrast to the normal porcine heart, the magnitude of the constriction induced in remodelled hearts by combined blockade of adenosine receptors and K<sub>ATP</sub> channels was virtually identical to that produced by blockade of K<sub>ATP</sub> channels alone [<xref ref-type="bibr" rid="CR71">71</xref>]. These findings could be interpreted to suggest that in remodelled myocardium the vasodilator influence of endogenous adenosine was entirely mediated through opening of K<sub>ATP</sub> channels, observations that are corroborated by findings in pressure-overload hypertrophied canine hearts [<xref ref-type="bibr" rid="CR65">65</xref>]. Taken together these observations in the porcine and canine coronary circulations suggest that, although the magnitude of the vasodilator influence exerted by endogenous adenosine was similar in normal and remodelled hearts, its effector pathway was different.</p>
        </sec>
      </sec>
      <sec id="Sec13">
        <title>Endothelial control</title>
        <p>Several studies have indicated that endothelial dysfunction, in particular a decreased production of NO and an increased production of endothelin, could aggravate LV dysfunction due to the peripheral vasoconstriction-induced increase in LV afterload, coronary vasoconstriction, and increased myocardial O<sub>2</sub> consumption [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR105">105</xref>].</p>
        <sec id="Sec14">
          <title>Nitric oxide</title>
          <p>Clinical studies indicate that chronic heart failure is accompanied by blunted vasodilator responses to endothelium-dependent receptor mediated vasodilators (particularly acetylcholine) in the microcirculation of the LV myocardium [<xref ref-type="bibr" rid="CR92">92</xref>], leg [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR57">57</xref>], and forearm [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. In the canine model of pacing-induced end-stage congestive heart failure, attenuated vasodilator responses of resistance vessels to acetylcholine in vivo have also been observed in the microvasculature of the hindleg circulation [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] and the coronary circulation [<xref ref-type="bibr" rid="CR105">105</xref>]. In swine with a 2&#x2013;3-week-old MI, we observed reduced vasodilator responses in the systemic and coronary microvasculature to ATP, in doses which we have previously shown to be completely abolished by pretreatment with the eNOS-inhibitor NLA [<xref ref-type="bibr" rid="CR26">26</xref>]. The findings of a blunted ATP-induced vasodilation are in agreement with the hypothesis that agonist-induced eNOS-mediated NO production is blunted 2&#x2013;3&#xA0;weeks after MI.</p>
          <p>A loss of NO-mediated vasodilation could enhance the progression of LV dysfunction to heart failure. This is supported by studies in dogs with pacing-induced dilated cardiomyopathy, in which the loss of basal NO production in the LV myocardium coincides with the progression from LV dysfunction to overt heart failure [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. However, in swine with a 2&#x2013;3-week-old MI, we did not find any evidence of a reduced coronary vasodilator influence of endogenous NO as decreases in coronary venous O<sub>2</sub> tension produced by NLA in resting and exercising MI swine were similar to those of normal swine (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>). In heart failure patients, studies on the contribution of NO to basal microvascular tone in the forearm, leg, or total systemic bed have yielded equivocal results with responses varying from blunted [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR64">64</xref>], to maintained [<xref ref-type="bibr" rid="CR60">60</xref>], and even enhanced [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR42">42</xref>] increases in vascular tone following NO synthase inhibition. It is possible that a maintained or increased NO production as observed in some studies, was the result of increased iNOS expression [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR79">79</xref>], as part of a generalized inflammatory response in end-stage heart failure, that occurred in the presence of either a decreased [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR86">86</xref>] or increased [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] eNOS expression. Since NLA can block all three isoforms of NOS [<xref ref-type="bibr" rid="CR7">7</xref>], we performed additional experiments, in which we blocked iNOS with aminoguanidine, to determine whether an upregulation of iNOS-mediated NO production masked a reduction in eNOS activity. iNOS blockade had no effect on coronary vasomotor tone, demonstrating that NO production via iNOS does not contribute significantly to vascular tone in MI swine, and, consequently, that basal and exercise-induced endothelial NO production is maintained early after MI [<xref ref-type="bibr" rid="CR44">44</xref>].
<fig id="Fig8"><label>Fig.&#xA0;8</label><caption><p>Effect of inhibition of NO synthase by NLA (20&#xA0;mg/kg iv) on myocardial O<sub>2</sub> extraction and coronary venous PO<sub>2</sub> at rest (lying) and during treadmill exercise in MI and N. Data are mean&#xA0;&#xB1;&#xA0;SEM. *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 NLA versus corresponding Control; there were no significant differences in the responses to NLA between MI and N either at rest or during exercise. Data are from Haitsma et al. [<xref ref-type="bibr" rid="CR44">44</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig8_HTML" id="MO8"/></fig>
</p>
          <p>The reason for the maintained basal and exercise-induced NO production in the presence of a blunted vasodilator response to ATP is unclear. However, Traverse et al. [<xref ref-type="bibr" rid="CR91">91</xref>] have shown that the amount of NO, produced after stimulation with an agonist is larger than the amount of NO produced during moderate exercise (60% increase in heart rate). Hence, the maximal capacity of NO production may be reduced, whereas the capacity of eNOS is sufficient to maintain basal and exercise-induced NO production. This explanation is unlikely since agonist-induced dilation is already affected at the lowest dose of administered ATP (which probably releases less NO than strenuous exercise). Moreover, higher doses of ATP still produce more dilation. Another explanation for the divergent results between ATP and exercise-induced increases in NO-production may be that ATP activates eNOS through a different mechanism than shear stress. ATP-induced activation of eNOS is mediated through a calcium-calmodulin dependent pathway [<xref ref-type="bibr" rid="CR74">74</xref>] whereas shear stress activates eNOS through Akt-mediated phosphorylation [<xref ref-type="bibr" rid="CR18">18</xref>], resulting in calcium-independent activation of eNOS. Hence, it is possible that perturbations in the calcium homeostasis of endothelial cells contributed to the selective impairment of ATP-induced vasodilation in swine with MI.</p>
        </sec>
        <sec id="Sec15">
          <title>Endothelin</title>
          <p>Despite the increased plasma levels of endogenous ET in swine with a 2&#x2013;3&#xA0;week old MI, its vasoconstrictor influence on the coronary circulation was reduced (Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref> [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]). To determine whether this was the result of blunted receptor responsiveness or reduced local ET-production, we studied the vasoconstriction induced by exogenous ET. The coronary vasoconstrictor influence to exogenous ET-1 in vivo was reduced after MI, indicating a reduced coronary vascular responsiveness to ET. Paradoxically, a recent study showed that ischemic heart disease results in upregulation of ET<sub>A</sub> and ET<sub>B</sub> receptor mRNA in human coronary arteries [<xref ref-type="bibr" rid="CR104">104</xref>]. This is in accordance with our measurements in isolated coronary arterioles obtained from sham-operated swine and swine with a MI, which showed that the ET responsiveness in vessels from animals with a MI was actually increased [<xref ref-type="bibr" rid="CR70">70</xref>]. The discrepancy between the in vivo and the in vitro findings suggests that ET receptor sensitivity is modulated in vivo, and that this modulation is apparently lost in vitro. Possible modulators of ET-receptor sensitivity are adenosine and NO, which have been shown to desensitize ET-receptors on the coronary vasculature [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>], and which may have been lost in the in vitro set-up due to lack of surrounding myocardium and intravascular blood flow. However, since we observed similar vasoconstrictor responses to blockade of adenosine receptors and NO production in MI and normal swine, these vasodilators would seem unlikely explanations for the observed reduced ET receptor sensitivity in MI swine in vivo.
<fig id="Fig9"><label>Fig.&#xA0;9</label><caption><p>Effect of ET<sub>A </sub>receptor blockade with EMD (3&#xA0;mg/kg iv) on myocardial oxygen balance in normal swine and swine with a recent MI. Data are means&#xA0;&#xB1;&#xA0;SE; *<italic>P&#xA0;</italic>&lt;&#xA0;0.05 versus corresponding Control relation, <sup>&#x2020;</sup>
<italic>P&#xA0;</italic>&lt;&#xA0;0.05 effect of EMD waned during exercise. Data are from Merkus et al. [<xref ref-type="bibr" rid="CR70">70</xref>]</p></caption><graphic xlink:href="11517_2008_315_Fig9_HTML" id="MO9"/></fig>
</p>
          <p>In conclusion, our observations suggest that when additional coronary vasodilation is required in the hypertrophied myocardium after MI, withdrawal of the ET-mediated vasoconstrictor influence contributes to a shift in vasomotor tone towards vasodilation. These findings may also explain in part why clinical trials of ET-receptor antagonists in heart failure have failed to show therapeutic value of these compounds [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR77">77</xref>].</p>
        </sec>
      </sec>
      <sec id="Sec16">
        <title>Conclusions and physiological relevance</title>
        <p>Under physiological circumstances, the heart matches its blood supply to the demand of the myocardium by altering the balance of vasodilator and vasoconstrictor influences, i.e. an increase in myocardial O<sub>2</sub> demand results in an increased influence of vasodilators (opening of K<sub>ATP</sub> channels, NO, adenosine [<xref ref-type="bibr" rid="CR53">53</xref>], &#x3B2;-adrenergic vasodilation [<xref ref-type="bibr" rid="CR27">27</xref>]) and a decreased influence of the potent vasoconstrictor endothelin-1 [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Studies from our laboratory performed during the past 10&#xA0;years have shown that following MI myocardial O<sub>2</sub> balance in the remodelled LV is perturbed, necessitating vasodilation and recruitment of coronary flow reserve, as evidenced by increased opening of K<sub>ATP</sub> channels [<xref ref-type="bibr" rid="CR71">71</xref>]. Importantly, however, not only an increased K<sub>ATP</sub> channel vasodilator influence, but also blunting of the coronary vasoconstrictor influences of endogenous endothelin [<xref ref-type="bibr" rid="CR70">70</xref>] and angiotensin II [<xref ref-type="bibr" rid="CR68">68</xref>], aid in preventing a more significant impairment of oxygen supply to the remodelled myocardium (Figs.&#xA0;<xref rid="Fig10" ref-type="fig">10</xref>, <xref rid="Fig11" ref-type="fig">11</xref>). Our studies suggest that generalized blunting of vasoconstrictor influences is one of the first adaptive mechanisms to reduce coronary resistance vessel tone and increase myocardial blood supply. This adaptation, which occurs in the healthy porcine heart during acute exercise, also appears operative in remodelled myocardium. Blunting of vasoconstrictor influences may be a physiologically favorable strategy, since it is more energy-efficient to blunt vasoconstrictor influences than to synthesize vasodilators.
<fig id="Fig10"><label>Fig.&#xA0;10</label><caption><p>Myocardial oxygen balance in normal and MI swine. Shown are the actual relations between MVO<sub>2</sub> and CVPO<sub>2</sub> in 30 normal swine (<italic>open circles</italic>) and 20 MI swine (<italic>open triangles</italic>) under control conditions. In addition, we have depicted the computed relations in MI swine if the ET (<italic>solid diamonds</italic>) and ANG II (<italic>solid squares</italic>) vasoconstrictor influences (which were both attenuated in MI swine) and the K<sub>ATP</sub> (<italic>solid triangles</italic>) vasodilator influences (which were enhanced in MI swine) would have been identical to those in normal swine. The <italic>graph</italic> clearly illustrates that the adaptations in coronary vasomotor control act to blunt perturbations in oxygen balance in remodelled myocardium of swine with a recent MI</p></caption><graphic xlink:href="11517_2008_315_Fig10_HTML" id="MO10"/></fig>
<fig id="Fig11"><label>Fig.&#xA0;11</label><caption><p>Alterations in vasomotor balance in the coronary resistance vessels within remodelled myocardium in swine with a 2&#x2013;3-week-old myocardial infarction</p></caption><graphic xlink:href="11517_2008_315_Fig11_HTML" id="MO11"/></fig>
</p>
        <p>Although the shift in coronary tone towards vasodilatation acts to blunt the flow perturbations in the remodelled heart, it does not appear to fully restore myocardial oxygen balance. This is also supported by the observation that K<sub>ATP</sub> channel activation is increased, consistent with the presence of metabolic distress. Whether these perturbations in myocardial oxygen delivery blood are sufficiently severe to contribute to the progressive deterioration of contractile function of the remodelled left ventricle remains to be established, but it is of interest to note that we previously found that troponin I proteolysis occurred in remodelled myocardium, which was associated with a loss of myofilament force development [<xref ref-type="bibr" rid="CR97">97</xref>]. Intermittent myocardial ischemia, as may occur in remodelled hearts during exercise or excitement, has been shown to be able to promote troponin I proteolysis [<xref ref-type="bibr" rid="CR38">38</xref>] and could thereby mediate the flow perturbation-induced progressive deterioration of LV function after MI. Definitive proof of our hypothesis must await future studies demonstrating that prevention of such flow perturbations will indeed prevent progressive loss of contractile function of the remodelled porcine left ventricle.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>Dr Merkus is supported by a post-doc stipend from the Netherlands Heart Foundation (2000T042).</p>
      <sec id="d29e1545">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azevedo</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Parasympathetic control of cardiac sympathetic activity: Normal ventricular function versus congestive heart failure</article-title>
          <source>Circulation</source>
          <year>1999</year>
          <volume>100</volume>
          <fpage>274</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.100.3.274</pub-id>
          <pub-id pub-id-type="pmid">10411852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bache</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Effects of hypertrophy on the coronary circulation</article-title>
          <source>Prog Cardiovasc Dis</source>
          <year>1988</year>
          <volume>30</volume>
          <fpage>403</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1016/0033-0620(88)90005-9</pub-id>
          <pub-id pub-id-type="pmid">2966968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bache</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>XZ</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of adenosine in coronary vasodilation during exercise</article-title>
          <source>Circ Res</source>
          <year>1988</year>
          <volume>62</volume>
          <fpage>846</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.62.4.846</pub-id>
          <pub-id pub-id-type="pmid">3349577</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batenburg</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Garrelds</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Bernasconi</surname>
              <given-names>CC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries</article-title>
          <source>Circulation</source>
          <year>2004</year>
          <volume>109</volume>
          <fpage>2296</fpage>
          <lpage>2301</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000128696.12245.57</pub-id>
          <pub-id pub-id-type="pmid">15117835</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berne</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Regulation of coronary blood flow</article-title>
          <source>Adv Cardiol</source>
          <year>1974</year>
          <volume>12</volume>
          <fpage>303</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="doi">10.1159/000395474</pub-id>
          <pub-id pub-id-type="pmid">4599839</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Binkley</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Nunziata</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: Demonstration in human subjects and verification in a paced canine model of ventricular failure</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1991</year>
          <volume>18</volume>
          <fpage>464</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1016/0735-1097(91)90602-6</pub-id>
          <pub-id pub-id-type="pmid">1856414</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ulrich</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes</article-title>
          <source>Mol Pharmacol</source>
          <year>2000</year>
          <volume>58</volume>
          <fpage>1026</fpage>
          <lpage>1034</lpage>
          <pub-id pub-id-type="pmid">11040050</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bristow</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Umans</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Beta<sub>1</sub>- and beta<sub>2</sub>-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta<sub>1</sub>-receptor down-regulation in heart failure</article-title>
          <source>Circ Res</source>
          <year>1986</year>
          <volume>59</volume>
          <fpage>297</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.59.3.297</pub-id>
          <pub-id pub-id-type="pmid">2876788</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabell</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of adenosine-induced coronary vasodilation by block of large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels</article-title>
          <source>Am J Physiol</source>
          <year>1994</year>
          <volume>267</volume>
          <fpage>H1455</fpage>
          <lpage>1460</lpage>
          <pub-id pub-id-type="pmid">7943391</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavallini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Tata</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Fierabracci</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>the enzymatic activity of adenosine metabolism in the rat heart. The effects of cardiac hypertrophy</article-title>
          <source>Cardiologia</source>
          <year>1992</year>
          <volume>37</volume>
          <fpage>659</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="pmid">1292873</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chidsey</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Augmentation of plasma norepinephrine response to exercise in patients with congestive heart failure</article-title>
          <source>New Engl J Med</source>
          <year>1962</year>
          <volume>267</volume>
          <fpage>650</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM196209272671305</pub-id>
          <pub-id pub-id-type="pmid">13878934</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Colucci</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zipes</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Pathophysiology of heart failure</article-title>
          <source>Heart disease</source>
          <year>2001</year>
          <edition>6</edition>
          <publisher-loc>Libby P. Philadelphia</publisher-loc>
          <publisher-name>W.B. Saunders company</publisher-name>
          <fpage>503</fpage>
          <lpage>533</lpage>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Czarnowski</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wojcik</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Langfort</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>5&#x2032;-Nucleotidase and adenosine deaminase activities in hypertrophied rat heart. The effect of tachycardia</article-title>
          <source>Rocz Akad Med Bialymst</source>
          <year>1996</year>
          <volume>41</volume>
          <fpage>334</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">9020545</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Gasparo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Catt</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Inagami</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>International union of pharmacology. XXIII. The angiotensin II receptors</article-title>
          <source>Pharmacol Rev</source>
          <year>2000</year>
          <volume>52</volume>
          <fpage>415</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="pmid">10977869</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Tata</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Simonetti</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The regional distribution of adenosine-regulating enzymes in the left and right ventricle walls of control and hypertrophic heart</article-title>
          <source>Basic Res Cardiol</source>
          <year>1989</year>
          <volume>84</volume>
          <fpage>597</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01906945</pub-id>
          <pub-id pub-id-type="pmid">2559711</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deussen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Metabolic flux rates of adenosine in the heart</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>2000</year>
          <volume>362</volume>
          <fpage>351</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1007/s002100000318</pub-id>
          <pub-id pub-id-type="pmid">11111829</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deussen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Quantitative integration of different sites of adenosine metabolism in the heart</article-title>
          <source>Ann Biomed Eng</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>877</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.1114/1.1308498</pub-id>
          <pub-id pub-id-type="pmid">11144671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimmeler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fisslthaler</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation</article-title>
          <source>Nature</source>
          <year>1999</year>
          <volume>399</volume>
          <fpage>601</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="doi">10.1038/21224</pub-id>
          <pub-id pub-id-type="pmid">10376603</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hablawetz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction</article-title>
          <source>Circulation</source>
          <year>1992</year>
          <volume>86</volume>
          <fpage>255</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.86.1.255</pub-id>
          <pub-id pub-id-type="pmid">1617777</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hayoz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Munzel</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelial function in chronic congestive heart failure</article-title>
          <source>Am J Cardiol</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>1596</fpage>
          <lpage>1601</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9149(92)90710-G</pub-id>
          <pub-id pub-id-type="pmid">1598876</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kastner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Strobel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>955</fpage>
          <lpage>963</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(98)00336-2</pub-id>
          <pub-id pub-id-type="pmid">9768717</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure</article-title>
          <source>Am J Physiol</source>
          <year>1992</year>
          <volume>262</volume>
          <fpage>H1640</fpage>
          <lpage>H1645</lpage>
          <pub-id pub-id-type="pmid">1621825</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Liem</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction</article-title>
          <source>Cardiovasc Res</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>889</fpage>
          <lpage>896</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cardiores.2004.12.010</pub-id>
          <pub-id pub-id-type="pmid">15721869</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Laxson</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Lindstrom</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise</article-title>
          <source>Cardiovasc Res</source>
          <year>1993</year>
          <volume>27</volume>
          <fpage>1592</fpage>
          <lpage>1597</lpage>
          <pub-id pub-id-type="doi">10.1093/cvr/27.9.1592</pub-id>
          <pub-id pub-id-type="pmid">8287435</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Oei</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of K<sub arrange="stack">ATP</sub><sup arrange="stack">+</sup> channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine</article-title>
          <source>Am J Physiol</source>
          <year>2001</year>
          <volume>280</volume>
          <fpage>H22</fpage>
          <lpage>H33</lpage>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Stubenitsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tonino</surname>
              <given-names>PA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O<sub>2</sub>-consumption in exercising swine</article-title>
          <source>Cardiovasc Res</source>
          <year>2000</year>
          <volume>47</volume>
          <fpage>738</fpage>
          <lpage>748</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(00)00143-7</pub-id>
          <pub-id pub-id-type="pmid">10974222</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Stubenitsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Verdouw</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control</article-title>
          <source>Circ Res</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>1312</fpage>
          <lpage>1322</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.82.12.1312</pub-id>
          <pub-id pub-id-type="pmid">9648728</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Stubenitsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Verdouw</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>275</volume>
          <fpage>H1663</fpage>
          <lpage>1672</lpage>
          <pub-id pub-id-type="pmid">9815074</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>van Zon</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Pavek</surname>
              <given-names>TJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endogenous adenosine mediates coronary vasodilation during exercise after K<sub arrange="stack">ATP</sub><sup arrange="stack">+</sup> channel blockade</article-title>
          <source>J Clin Invest</source>
          <year>1995</year>
          <volume>95</volume>
          <fpage>285</fpage>
          <lpage>295</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI117653</pub-id>
          <pub-id pub-id-type="pmid">7814627</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eckberg</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Drabinsky</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Defective cardiac parasympathetic control in patients with heart disease</article-title>
          <source>N Engl J Med</source>
          <year>1971</year>
          <volume>285</volume>
          <fpage>877</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM197110142851602</pub-id>
          <pub-id pub-id-type="pmid">4398792</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farouque</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Worthley</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>IT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans</article-title>
          <source>Circ Res</source>
          <year>2002</year>
          <volume>90</volume>
          <fpage>231</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1161/hh0202.103713</pub-id>
          <pub-id pub-id-type="pmid">11834717</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fowler</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Laser</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>GL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response</article-title>
          <source>Circulation</source>
          <year>1986</year>
          <volume>74</volume>
          <fpage>1290</fpage>
          <lpage>1302</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.74.6.1290</pub-id>
          <pub-id pub-id-type="pmid">3022962</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Heart failure in 1991</article-title>
          <source>Cardiology</source>
          <year>1991</year>
          <volume>78</volume>
          <fpage>81</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1159/000174771</pub-id>
          <pub-id pub-id-type="pmid">1676934</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Pathophysiology of chronic heart failure</article-title>
          <source>Am J Med</source>
          <year>2001</year>
          <volume>110</volume>
          <issue>Suppl 7A</issue>
          <fpage>37S</fpage>
          <lpage>46S</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9343(98)00385-4</pub-id>
          <pub-id pub-id-type="pmid">11334774</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ziesche</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1985</year>
          <volume>5</volume>
          <fpage>832</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(85)80420-4</pub-id>
          <pub-id pub-id-type="pmid">3973288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ziesche</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure</article-title>
          <source>Am J Cardiol</source>
          <year>1982</year>
          <volume>49</volume>
          <fpage>1152</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9149(82)90039-X</pub-id>
          <pub-id pub-id-type="pmid">7064841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Giaid</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy</article-title>
          <source>Circulation</source>
          <year>1998</year>
          <volume>98</volume>
          <fpage>132</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.98.2.132</pub-id>
          <pub-id pub-id-type="pmid">9679719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Atar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of troponin I proteolysis in the pathogenesis of stunned myocardium</article-title>
          <source>Circ Res</source>
          <year>1997</year>
          <volume>80</volume>
          <fpage>393</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="pmid">9048660</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorman</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Tune</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Richmond</surname>
              <given-names>KN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Feedforward sympathetic coronary vasodilation in exercising dogs</article-title>
          <source>J Appl Physiol</source>
          <year>2000</year>
          <volume>89</volume>
          <fpage>1892</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="pmid">11053341</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gottlieb</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>The neurohormonal paradigm: Have we gone too far?</article-title>
          <source>J Am College Cardiol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>1458</fpage>
          <lpage>1459</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(03)00195-5</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafson</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Downregulation of 5&#x2032;-nucleotidase in rabbit heart during coronary underperfusion</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>274</volume>
          <fpage>H529</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="pmid">9486257</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Habib</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dutka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Crossman</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?</article-title>
          <source>Lancet</source>
          <year>1994</year>
          <volume>344</volume>
          <fpage>371</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(94)91402-8</pub-id>
          <pub-id pub-id-type="pmid">7914308</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Bac</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Raja</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations</article-title>
          <source>Cardiovasc Res</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>471</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(01)00426-6</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vermeulen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction</article-title>
          <source>Am J Physiol</source>
          <year>2002</year>
          <volume>282</volume>
          <fpage>H2198</fpage>
          <lpage>H2209</lpage>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hambrecht</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fiehn</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Weigl</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure</article-title>
          <source>Circulation</source>
          <year>1998</year>
          <volume>98</volume>
          <fpage>2709</fpage>
          <lpage>2715</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.98.24.2709</pub-id>
          <pub-id pub-id-type="pmid">9851957</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heaps</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Bowles</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Gender-specific K<sup>+</sup>-channel contribution to adenosine-induced relaxation in coronary arterioles</article-title>
          <source>J Appl Physiol</source>
          <year>2002</year>
          <volume>92</volume>
          <fpage>550</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="doi">10.1152/japplphysiol.00566.2001</pub-id>
          <pub-id pub-id-type="pmid">11796663</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hein</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Belardinelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A<sup>2A</sup> receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>1999</year>
          <volume>291</volume>
          <fpage>655</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="pmid">10525085</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hein</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and K<sub>ATP</sub> channels</article-title>
          <source>Circ Res</source>
          <year>1999</year>
          <volume>85</volume>
          <fpage>634</fpage>
          <lpage>642</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.85.7.634</pub-id>
          <pub-id pub-id-type="pmid">10506488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helmer</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>McKirnan</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Shabetai</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure</article-title>
          <source>Circulation</source>
          <year>1996</year>
          <volume>94</volume>
          <fpage>2260</fpage>
          <lpage>2267</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.94.9.2260</pub-id>
          <pub-id pub-id-type="pmid">8901681</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heymes</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vanderheyden</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bronzwaer</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>1999</year>
          <volume>99</volume>
          <fpage>3009</fpage>
          <lpage>3016</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.99.23.3009</pub-id>
          <pub-id pub-id-type="pmid">10368118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heyndrickx</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Muylaert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pannier</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Alpha-adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs</article-title>
          <source>Am J Physiol</source>
          <year>1982</year>
          <volume>242</volume>
          <fpage>H805</fpage>
          <lpage>H809</lpage>
          <pub-id pub-id-type="pmid">7081452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirooka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of l-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure</article-title>
          <source>Circulation</source>
          <year>1994</year>
          <volume>90</volume>
          <fpage>658</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.90.2.658</pub-id>
          <pub-id pub-id-type="pmid">8044935</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishibashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atp-sensitive k<sup>+</sup> channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise</article-title>
          <source>Circ Res</source>
          <year>1998</year>
          <volume>82</volume>
          <fpage>346</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.82.3.346</pub-id>
          <pub-id pub-id-type="pmid">9486663</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalkman</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Bilgin</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>van Haren</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding</article-title>
          <source>Cardiovasc Res</source>
          <year>1996</year>
          <volume>32</volume>
          <fpage>1088</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(96)00166-6</pub-id>
          <pub-id pub-id-type="pmid">9015411</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Wicker</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy</article-title>
          <source>Circulation</source>
          <year>1990</year>
          <volume>81</volume>
          <fpage>238</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.81.1.238</pub-id>
          <pub-id pub-id-type="pmid">2137045</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <source>Heart failure, pathophysiology, molecular biology, and clinical management</source>
          <year>2000</year>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Biasucci</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sabba</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>918</fpage>
          <lpage>925</lpage>
          <pub-id pub-id-type="doi">10.1016/0735-1097(92)90271-N</pub-id>
          <pub-id pub-id-type="pmid">1552112</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Krum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: Role of endothelium-derived nitric oxide</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>585</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="doi">10.1016/0735-1097(96)00204-5</pub-id>
          <pub-id pub-id-type="pmid">8772743</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiowski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sutsch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schalcher</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelial control of vascular tone in chronic heart failure</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>S67</fpage>
          <lpage>S73</lpage>
          <pub-id pub-id-type="pmid">9883751</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubo</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Rector</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Bank</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lack of contribution of nitric oxide to basal vasomotor tone in heart failure</article-title>
          <source>Am J Cardiol</source>
          <year>1994</year>
          <volume>74</volume>
          <fpage>1133</fpage>
          <lpage>1136</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9149(94)90466-9</pub-id>
          <pub-id pub-id-type="pmid">7977073</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laxson</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Homans</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Bache</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>H1471</fpage>
          <lpage>1477</lpage>
          <pub-id pub-id-type="pmid">8238557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lefroy</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Wharton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Crake</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regional changes in angiotensin II receptor density after experimental myocardial infarction</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>429</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1006/jmcc.1996.0039</pub-id>
          <pub-id pub-id-type="pmid">8729073</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Lorell</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Ingelfinger</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution and function of cardiac angiotensin AT<sub>1</sub>- and AT<sub>2</sub>-receptor subtypes in hypertrophied rat hearts</article-title>
          <source>Am J Physiol</source>
          <year>1994</year>
          <volume>267</volume>
          <fpage>H844</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="pmid">8067441</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maguire</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Nugent</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>McGurk</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent</article-title>
          <source>Heart</source>
          <year>1998</year>
          <volume>80</volume>
          <fpage>141</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="doi">10.1136/hrt.80.2.141</pub-id>
          <pub-id pub-id-type="pmid">9813559</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melchert</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Traverse</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of K<sub arrange="stack">ATP</sub><sup arrange="stack">+</sup> channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle</article-title>
          <source>Am J Physiol</source>
          <year>1999</year>
          <volume>277</volume>
          <fpage>H617</fpage>
          <lpage>H625</lpage>
          <pub-id pub-id-type="pmid">10444487</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Chilian</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Metabolic regulation of coronary vascular tone: Role of endothelin-1</article-title>
          <source>Am J Physiol</source>
          <year>2002</year>
          <volume>283</volume>
          <fpage>H1915</fpage>
          <lpage>H1921</lpage>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>TY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways</article-title>
          <source>Am J Physiol</source>
          <year>2003</year>
          <volume>285</volume>
          <fpage>H424</fpage>
          <lpage>H433</lpage>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Sorop</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction</article-title>
          <source>Am J Physiol</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>H2082</fpage>
          <lpage>2089</lpage>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Houweling</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mirza</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation</article-title>
          <source>Cardiovasc Res</source>
          <year>2003</year>
          <volume>59</volume>
          <fpage>745</fpage>
          <lpage>754</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(03)00479-6</pub-id>
          <pub-id pub-id-type="pmid">14499876</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Houweling</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>van den Meiracker</surname>
              <given-names>AH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction</article-title>
          <source>Am J Physiol</source>
          <year>2005</year>
          <volume>288</volume>
          <fpage>H871</fpage>
          <lpage>H880</lpage>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Houweling</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>van Vliet</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contribution of K<sub arrange="stack">ATP</sub><sup arrange="stack">+</sup> channels to coronary vasomotor tone regulation is enhanced in exercising swine with a recent myocardial infarction</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2005</year>
          <volume>288</volume>
          <fpage>H1306</fpage>
          <lpage>H1313</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00631.2004</pub-id>
          <pub-id pub-id-type="pmid">15539425</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sorop</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Houweling</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine</article-title>
          <source>Am J Physiol</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>H2075</fpage>
          <lpage>H2081</lpage>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stepp</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine preconditions against endothelin-induced constriction of coronary arterioles</article-title>
          <source>Am J Physiol</source>
          <year>2000</year>
          <volume>279</volume>
          <fpage>H2593</fpage>
          <lpage>H2597</lpage>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motte</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pirotton</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells</article-title>
          <source>Int J Biochem Cell Biol</source>
          <year>1995</year>
          <volume>27</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/1357-2725(94)00059-X</pub-id>
          <pub-id pub-id-type="pmid">7757878</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Narula</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haider</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Arbustini</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of disease: apoptosis in heart failure-seeing hope in death</article-title>
          <source>Nat Clin Pract Cardiovasc Med</source>
          <year>2006</year>
          <volume>3</volume>
          <fpage>681</fpage>
          <lpage>688</lpage>
          <pub-id pub-id-type="doi">10.1038/ncpcardio0710</pub-id>
          <pub-id pub-id-type="pmid">17122801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nolan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Flapan</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Capewell</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function</article-title>
          <source>Br Heart J</source>
          <year>1992</year>
          <volume>67</volume>
          <fpage>482</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="doi">10.1136/hrt.67.6.482</pub-id>
          <pub-id pub-id-type="pmid">1622699</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gattis</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>KF</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the randomized intravenous tezosentan study (RITZ-4)</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>1452</fpage>
          <lpage>1457</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(03)00194-3</pub-id>
          <pub-id pub-id-type="pmid">12742280</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oikawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Maehara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>1188</fpage>
          <lpage>1194</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(01)01494-2</pub-id>
          <pub-id pub-id-type="pmid">11583902</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heras</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morales-Ruiz</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nitric oxide synthase II mRNA expression in cardiac tissue of patients with heart failure undergoing cardiac transplantation</article-title>
          <source>J Heart Lung Transplant</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>139</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1016/S1053-2498(99)00126-6</pub-id>
          <pub-id pub-id-type="pmid">10703689</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Recchia</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>McConnell</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>RD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog</article-title>
          <source>Circ Res</source>
          <year>1998</year>
          <volume>83</volume>
          <fpage>969</fpage>
          <lpage>979</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.83.10.969</pub-id>
          <pub-id pub-id-type="pmid">9815144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samaha</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Heineman</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Ince</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo</article-title>
          <source>Am J Physiol</source>
          <year>1992</year>
          <volume>262</volume>
          <fpage>C1220</fpage>
          <lpage>C1227</lpage>
          <pub-id pub-id-type="pmid">1590361</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schaper</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Remijsen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Xhonneux</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The size of myocardial infarction after experimental coronary artery ligation</article-title>
          <source>Z Kreislaufforsch</source>
          <year>1969</year>
          <volume>58</volume>
          <fpage>904</fpage>
          <lpage>909</lpage>
          <pub-id pub-id-type="pmid">5375039</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schrier</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>WT</given-names>
            </name>
          </person-group>
          <article-title>Hormones and hemodynamics in heart failure</article-title>
          <source>N Engl J Med</source>
          <year>1999</year>
          <volume>341</volume>
          <fpage>577</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199908193410806</pub-id>
          <pub-id pub-id-type="pmid">10451464</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuijt</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Basdew</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Veghel</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>AT<sub>2</sub> receptor-mediated vasodilation in the heart: effect of myocardial infarction</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2001</year>
          <volume>281</volume>
          <fpage>H2590</fpage>
          <lpage>2596</lpage>
          <pub-id pub-id-type="pmid">11709427</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shannon</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Komamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>YT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>H801</fpage>
          <lpage>H809</lpage>
          <pub-id pub-id-type="pmid">8214113</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hoegler</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced gene expression of vascular endothelial no synthase and cyclooxygenase-1 in heart failure</article-title>
          <source>Circ Res</source>
          <year>1996</year>
          <volume>78</volume>
          <fpage>58</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.78.1.58</pub-id>
          <pub-id pub-id-type="pmid">8603506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spinale</surname>
              <given-names>FG</given-names>
            </name>
          </person-group>
          <article-title>Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function</article-title>
          <source>Physiol Rev</source>
          <year>2007</year>
          <volume>87</volume>
          <fpage>1285</fpage>
          <lpage>1342</lpage>
          <pub-id pub-id-type="doi">10.1152/physrev.00012.2007</pub-id>
          <pub-id pub-id-type="pmid">17928585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spinale</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Grine</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Tempel</surname>
              <given-names>GE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy</article-title>
          <source>Basic Res Cardiol</source>
          <year>1992</year>
          <volume>87</volume>
          <fpage>65</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00795391</pub-id>
          <pub-id pub-id-type="pmid">1567354</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spinale</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Hendrick</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>FA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine</article-title>
          <source>Am J Physiol</source>
          <year>1990</year>
          <volume>259</volume>
          <fpage>H218</fpage>
          <lpage>H229</lpage>
          <pub-id pub-id-type="pmid">2375409</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traverse</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Melchert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pierpont</surname>
              <given-names>GL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of myocardial blood flow by oxygen consumption is maintained in the failing heart during exercise</article-title>
          <source>Circ Res</source>
          <year>1999</year>
          <volume>84</volume>
          <fpage>401</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.84.4.401</pub-id>
          <pub-id pub-id-type="pmid">10066674</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traverse</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary nitric oxide production in response to exercise and endothelium-dependent agonists</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>2526</fpage>
          <lpage>2531</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.101.21.2526</pub-id>
          <pub-id pub-id-type="pmid">10831528</pub-id>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Treasure</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Vita</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>1990</year>
          <volume>81</volume>
          <fpage>772</fpage>
          <lpage>779</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.81.3.772</pub-id>
          <pub-id pub-id-type="pmid">2306829</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tune</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Richmond</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>MW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise</article-title>
          <source>Am J Physiol</source>
          <year>2000</year>
          <volume>278</volume>
          <fpage>H74</fpage>
          <lpage>H84</lpage>
        </element-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Heuvel</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Blanksma</surname>
              <given-names>PK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients</article-title>
          <source>Cardiovasc Res</source>
          <year>2002</year>
          <volume>55</volume>
          <fpage>97</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(02)00331-0</pub-id>
          <pub-id pub-id-type="pmid">12062712</pub-id>
        </element-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Heuvel</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Blanksma</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Siebelink</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril</article-title>
          <source>Int J Cardiovasc Imaging</source>
          <year>2001</year>
          <volume>17</volume>
          <fpage>353</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1011971800052</pub-id>
          <pub-id pub-id-type="pmid">12025949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van der Giessen</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Van Woerkens</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>653</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="doi">10.1097/00005344-198910000-00019</pub-id>
          <pub-id pub-id-type="pmid">2478781</pub-id>
        </element-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Velden</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Merkus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Klarenbeek</surname>
              <given-names>BR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction</article-title>
          <source>Circ Res</source>
          <year>2004</year>
          <volume>95</volume>
          <fpage>e85</fpage>
          <lpage>e95</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000149531.02904.09</pub-id>
          <pub-id pub-id-type="pmid">15528471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Kats</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Haitsma</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II</article-title>
          <source>Circulation</source>
          <year>2000</year>
          <volume>102</volume>
          <fpage>1556</fpage>
          <lpage>1563</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.102.13.1556</pub-id>
          <pub-id pub-id-type="pmid">11004147</pub-id>
        </element-citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Veldhuisen</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>van den Heuvel</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Blanksma</surname>
              <given-names>PK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemia and left ventricular dysfunction: a reciprocal relation?</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1998</year>
          <volume>32</volume>
          <issue>Suppl 1</issue>
          <fpage>S46</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">9731695</pub-id>
        </element-citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Woerkens</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>van der Giessen</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Verdouw</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure</article-title>
          <source>Crit Care Med</source>
          <year>1993</year>
          <volume>21</volume>
          <fpage>420</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1097/00003246-199303000-00021</pub-id>
          <pub-id pub-id-type="pmid">8440113</pub-id>
        </element-citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vatner</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Asai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Iwase</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart</article-title>
          <source>Am J Cardiol</source>
          <year>1999</year>
          <volume>83</volume>
          <fpage>80H</fpage>
          <lpage>85H</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9149(99)00266-0</pub-id>
          <pub-id pub-id-type="pmid">10750593</pub-id>
        </element-citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vatner</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Hittinger</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy</article-title>
          <source>Basic Res Cardiol</source>
          <year>1993</year>
          <volume>88</volume>
          <fpage>81</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">8357337</pub-id>
        </element-citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wackenfors</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Emilson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ingemansson</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic heart disease down-regulates angiotensin type 1 receptor mRNA in human coronary arteries</article-title>
          <source>Eur J Pharmacol</source>
          <year>2004</year>
          <volume>503</volume>
          <fpage>147</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejphar.2004.09.039</pub-id>
          <pub-id pub-id-type="pmid">15496309</pub-id>
        </element-citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wackenfors</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Emilson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ingemansson</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic heart disease induce upregulation of endothelin receptor mrna in human coronary arteries</article-title>
          <source>Eur J Pharmacol</source>
          <year>2004</year>
          <volume>484</volume>
          <fpage>103</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejphar.2003.11.001</pub-id>
          <pub-id pub-id-type="pmid">14729387</pub-id>
        </element-citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seyedi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure</article-title>
          <source>Am J Physiol</source>
          <year>1994</year>
          <volume>266</volume>
          <fpage>H670</fpage>
          <lpage>680</lpage>
          <pub-id pub-id-type="pmid">8141368</pub-id>
        </element-citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Egashira</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Arimura</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Coronary vascular K<sup>+</sup><sub>ATP</sub> channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure</article-title>
          <source>Jpn Circ J</source>
          <year>2000</year>
          <volume>64</volume>
          <fpage>701</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="doi">10.1253/jcj.64.701</pub-id>
          <pub-id pub-id-type="pmid">10981856</pub-id>
        </element-citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hein</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Divergent roles of angiotensin II AT<sub>1</sub> and AT<sub>2</sub> receptors in modulating coronary microvascular function</article-title>
          <source>Circ Res</source>
          <year>2003</year>
          <volume>92</volume>
          <fpage>322</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000056759.53828.2C</pub-id>
          <pub-id pub-id-type="pmid">12595345</pub-id>
        </element-citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wilke</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study</article-title>
          <source>Circulation</source>
          <year>1996</year>
          <volume>94</volume>
          <fpage>1089</fpage>
          <lpage>1100</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.94.5.1089</pub-id>
          <pub-id pub-id-type="pmid">8790051</pub-id>
        </element-citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure</article-title>
          <source>Circulation</source>
          <year>1995</year>
          <volume>91</volume>
          <fpage>2655</fpage>
          <lpage>2663</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.91.10.2655</pub-id>
          <pub-id pub-id-type="pmid">7743629</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>